Oberweis Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-42,770
| Closed | -$470K | – | 163 |
|
|
2017
Q1 | $470K | Sell |
42,770
-27,000
| -39% | -$297K | 0.14% | 104 |
|
|
2016
Q4 | $945K | Buy |
69,770
+14,700
| +27% | +$199K | 0.28% | 68 |
|
|
2016
Q3 | $678K | Buy |
+55,070
| New | +$678K | 0.2% | 85 |
|
|
2016
Q1 | – | Sell |
-96,630
| Closed | -$1.67M | – | 201 |
|
|
2015
Q4 | $1.67M | Buy |
96,630
+30,577
| +46% | +$529K | 0.47% | 43 |
|
|
2015
Q3 | $1.31M | Buy |
66,053
+44,853
| +212% | +$891K | 0.38% | 42 |
|
|
2015
Q2 | $348K | Sell |
21,200
-2,600
| -11% | -$42.7K | 0.09% | 134 |
|
|
2015
Q1 | $370K | Sell |
23,800
-29,500
| -55% | -$459K | 0.1% | 121 |
|
|
2014
Q4 | $761K | Buy |
53,300
+1,600
| +3% | +$22.8K | 0.23% | 63 |
|
|
2014
Q3 | $336K | Sell |
51,700
-29,000
| -36% | -$188K | 0.09% | 110 |
|
|
2014
Q2 | $557K | Sell |
80,700
-13,300
| -14% | -$91.8K | 0.14% | 105 |
|
|
2014
Q1 | $672K | Buy |
94,000
+41,000
| +77% | +$293K | 0.14% | 105 |
|
|
2013
Q4 | $498K | Buy |
+53,000
| New | +$498K | 0.12% | 99 |
|